Avi Veidman

Avi Veidman is at the forefront of cancer treatment care as the CEO of Nucleai, a premier AI-powered spatial biology solution. Under his leadership, Nucleai is enhancing drug R&D and clinical treatment decisions by creating phenotype maps from pathology slides and integrating them with comprehensive data layers, including clinical and genomic information.

Posts by Avi Veidman

MedCity Influencers

Targeting the Blast Radius: Why Spatial AI Diagnostics Are Crucial for Maximizing the Impact of Antibody-Drug Conjugates

As the field of oncology evolves, we need to shift away from traditional binary “yes-no” biomarkers to a more nuanced, spatial understanding of tumor biology. This approach will allow for more personalized treatment plans that are tailored to the unique characteristics of each patient’s tumor.

Health IT

Accelerating Claim Processing: Strategies to Shorten the Life of a Claim

These strategies and practices can significantly shorten the life cycle of claims, leading to quicker resolutions and improved financial outcomes.

By Greenway Health

Health Tech

What’s Keeping Healthcare CIOs Up at Night: How to Improve Patient Satisfaction by Handling Calls More Efficiently

Health systems have spent billions on portals while investments in modernizing the voice channel — the dominant preference of healthcare consumers — have taken a backseat.

By Stephanie Baum

Health Tech

What’s Keeping Healthcare CIOs Up at Night: How to Improve Patient Satisfaction by Handling Calls More Efficiently

Health systems have spent billions on portals while investments in modernizing the voice channel — the dominant preference of healthcare consumers — have taken a backseat.

By Stephanie Baum